Characterisation of MRSA strains isolated from patients in a hospital in Riyadh, Kingdom of Saudi Arabia

BMC Microbiology

Ralf Ehricht³  Peter Slickers³  Ahmed Hakawi¹  Sameeh S Ghazal¹  Antje Ruppelt²  Rami Hasan⁴  Leila Skakni⁴  Stefan Monecke³ 

[1] Infection Control & Environmental Health Department King Fahad Medical City, PO Box 59046, Riyadh, 11525, Kingdom of Saudi Arabia;Institute for Medical Microbiology and Hygiene, Technical University of Dresden, Dresden, Germany;Alere Technologies GmbH, Jena, Germany;Molecular Pathology Laboratory, King Fahad Medical City, PO Box 59046, Riyadh, 11525, Kingdom of Saudi Arabia

关键词: Saudi-Arabia;    Panton-Valentine leukocidin;    MRSA;    Staphylococcus aureus;   

Others  :  1221818
DOI  :  10.1186/1471-2180-12-146

 received in 2011-12-29, accepted in 2012-07-02,  发布年份 2012

【 摘 要 】

Background

Methicillin-resistant Staphylococcus aureus (MRSA) is spreading worldwide and poses a serious public health problem, being present in hospital settings and communities. However, from the Middle East and the Arabian Peninsula few molecular typing data on MRSA strains are currently available. In order to obtain data on the population structure of MRSA in Riyadh, Saudi Arabia, 107 clinical and environmental MRSA isolates were genotyped using a microarray-based assay.

Results

Five major MRSA strains from four clonal complexes were identified CC8/ST239-III (20.75%), PVL-positive as well as -negative CC22-IV (18.87% and 9.43%, respectively), PVL-positive CC30-IV (12.26%) and PVL-positive CC80-IV (17.92%). Minor strains, which accounted for less than 3% each, included CC1-IV/SCCfus, PVL-positive CC1/ST772-V, PVL-positive as well as- negative CC5-IV, CC5-IV/SCCfus, CC5-V, CC6-IV, CC45-IV, PVL-negative CC80-IV, PVL-positive CC88-IV, CC97-V and a CC9/ST834-MRSA strain.

Conclusions

Typing of MRSA strains from Riyadh revealed a high diversity of clonal complexes. The prevalence of the genes encoding the Panton-Valentine leukocidin was surprisingly high (54.21%), and a significant rate of resistance markers was detected also in strains considered as community-associated.

【 授权许可】

   
2012 Monecke et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Humphreys H, Carroll JD, Keane CT, Cafferkey MT, Pomeroy HM, Coleman DC: Importation of methicillin-resistant Staphylococcus aureus from Baghdad to Dublin and subsequent nosocomial spread. J Hosp Infect 1990, 15(2):127-135.
• [2]Weber S, Ehricht R, Slickers P, Abdel-Wareth L, Donnelly G, Pitout M, Monecke S: Genetic fingerprinting of MRSA from Abu Dhabi. ECCMID: 2010, Vienna; 2010.
• [3]Fatholahzadeh B, Emaneini M, Aligholi M, Gilbert G, Taherikalani M, Jonaidi N, Eslampour MA, Feizabadi MM: Molecular characterization of methicillin-resistant Staphylococcus aureus clones from a teaching hospital in Tehran. Jpn J Infect Dis 2009, 62(4):309-311.
• [4]Cirlan M, Saad M, Coman G, Bilal NE, Elbashier AM, Kreft D, Snijders S, van Leeuwen W, van Belkum A: International spread of major clones of methicillin resistant Staphylococcus aureus: nosocomial endemicity of multi locus sequence type 239 in Saudi Arabia and Romania. Infect Genet Evol 2005, 5(4):335-339.
• [5]Alp E, Klaassen CH, Doganay M, Altoparlak U, Aydin K, Engin A, Kuzucu C, Ozakin C, Ozinel MA, Turhan O, et al.: MRSA genotypes in Turkey: persistence over 10 years of a single clone of ST239. J Infect 2009, 58(6):433-438.
• [6]Chongtrakool P, Ito T, Ma XX, Kondo Y, Trakulsomboon S, Tiensasitorn C, Jamklang M, Chavalit T, Song JH, Hiramatsu K: Staphylococcal cassette chromosome mec (SCCmec) typing of methicillin-resistant Staphylococcus aureus strains isolated in 11 Asian countries: a proposal for a new nomenclature for SCCmec elements. Antimicrob Agents Chemother 2006, 50(3):1001-1012.
• [7]Udo EE, Al-Sweih N, Noronha B: Characterisation of non-multiresistant methicillin-resistant Staphylococcus aureus (including EMRSA-15) in Kuwait Hospitals. Clin Microbiol Infect 2006, 12(3):262-269.
• [8]Udo EE, O'Brien FG, Al-Sweih N, Noronha B, Matthew B, Grubb WB: Genetic lineages of community-associated methicillin-resistant Staphylococcus aureus in Kuwait hospitals. J Clin Microbiol 2008, 46(10):3514-3516.
• [9]Tokajian ST, Khalil PA, Jabbour D, Rizk M, Farah MJ, Hashwa FA, Araj GF: Molecular characterization of Staphylococcus aureus in Lebanon. Epidemiol Infect 2010, 138(5):707-712.
• [10]Enany S, Higuchi W, Okubo T, Takano T, Enany M, Yamamoto T: Brain abscess caused by Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus in Egypt, April 2007. Euro Surveill 2007, 12(9):E070927-070922.
• [11]Ben Nejma M, Mastouri M, Bel Hadj Jrad B, Nour M: Characterization of ST80 Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus clone in Tunisia. Diagn Microbiol Infect Dis 2008.
• [12]Bekkhoucha SN, Cady A, Gautier P, Itim F, Donnio PY: A portrait of Staphylococcus aureus from the other side of the Mediterranean Sea: molecular characteristics of isolates from Western Algeria. Eur J Clin Microbiol Infect Dis 2009, 28(5):553-555.
• [13]Antri K, Rouzic N, Dauwalder O, Boubekri I, Bes M, Lina G, Vandenesch F, Tazir M, Ramdani-Bouguessa N, Etienne J: High prevalence of methicillin-resistant Staphylococcus aureus clone ST80-IV in hospital and community settings in Algiers. Clin Microbiol Infect 2011, 17(4):526-532.
• [14]Maier J, Melzl H, Reischl U, Drubel I, Witte W, Lehn N, Linde H: Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus in Germany associated with travel or foreign family origin. Eur J Clin Microbiol Infect Dis 2005, 24(9):637-639.
• [15]Balkhy HH, Memish ZA, Almuneef MA, Cunningham GC, Francis C, Fong KC, Nazeer ZB, Tannous E: Methicillin-resistant Staphylococcus aureus: a 5-year review of surveillance data in a tertiary care hospital in Saudi Arabia. Infect Control Hosp Epidemiol 2007, 28(8):976-982.
• [16]Al-Tawfiq JA: Incidence and epidemiology of methicillin-resistant Staphylococcus aureus infection in a Saudi Arabian Hospital, 1999–2003. Infect Control Hosp Epidemiol 2006, 27(10):1137-1139.
• [17]Ghazal S, Hakawi A, Syam C: King Fahad Medical City (KFMC) MRSA Prevention & Control program. KFMC Clinical Research Symposium, Riyadh; 2010.
• [18]Asghar AH, Momenah AM: Methicillin Resistance among Staphylococcus aureus Isolates from Saudi Hospitals. Med Princ Pract 2006, 15(1):52-55.
• [19]Bukharie HA: Increasing threat of community-acquired methicillin-resistant Staphylococcus aureus. Am J Med Sci 2010, 340(5):378-381.
• [20]Monecke S, Coombs G, Shore AC, Coleman DC, Akpaka P, Borg M, Chow H, Ip M, Jatzwauk L, Jonas D, et al.: A Field Guide to Pandemic, Epidemic and Sporadic Clones of Methicillin-Resistant Staphylococcus aureus. PLoS One 2011, 6(4):e17936.
• [21]Monecke S, Slickers P, Ehricht R: Assignment of Staphylococcus aureus isolates to clonal complexes based on microarray analysis and pattern recognition. FEMS Immunol Med Microbiol 2008, 53:237-251.
• [22]Scicluna E, Shore A, Thuermer A, Ehricht R, Slickers P, Borg M, Coleman D, Monecke S: Characterisation of MRSA from Malta and the description of a Maltese epidemic MRSA strain. Eur J Clin Microbiol Infect Dis 2010, 29(2):163-170.
• [23]Coombs GW, Pearson JC, O'Brien FG, Murray RJ, Grubb WB, Christiansen KJ: Methicillin-resistant Staphylococcus aureus clones, Western Australia. Emerg Infect Dis 2006, 12(2):241-247.
• [24]Holden MTG, Lindsay JA, Corton C, Quail MA, Cockfield JD, Pathak S, Batra R, Parkhill J, Bentley SD, Edgeworth JD: Genome sequence of a recently emerged highly-transmissible, multi-antibiotic and antiseptic resistant, variant of methicillin-resistant Staphylococcus aureus (MRSA) sequence-type 239 (TW). J Bacteriol 2009, JB:01255-01209.
• [25]Robinson DA, Enright MC: Evolution of Staphylococcus aureus by Large Chromosomal Replacements. J Bacteriol 2004, 186(4):1060-1064.
• [26]Conceicao T, Tavares A, Miragaia M, Hyde K, Aires-de-Sousa M, de Lencastre H: Prevalence and clonality of methicillin-resistant Staphylococcus aureus (MRSA) in the Atlantic Azores islands: predominance of SCCmec types IV, V and VI. Eur J Clin Microbiol Infect Dis 2010, 29(5):543-550.
• [27]Rossney AS, Lawrence MJ, Morgan PM, Fitzgibbon MM, Shore A, Coleman DC, Keane CT, O'Connell B: Epidemiological typing of MRSA isolates from blood cultures taken in Irish hospitals participating in the European Antimicrobial Resistance Surveillance System (1999–2003). Eur J Clin Microbiol Infect Dis 2006, 25(2):79-89.
• [28]Shore AC, Rossney AS, Kinnevey PM, Brennan OM, Creamer E, Sherlock O, Dolan A, Cunney R, Sullivan DJ, Goering RV, et al.: Enhanced discrimination of highly clonal ST22-methicillin-resistant Staphylococcus aureus IV isolates achieved by combining spa, dru, and pulsed-field gel electrophoresis typing data. J Clin Microbiol 2010, 48(5):1839-1852.
• [29]Ellington MJ, Hope R, Livermore DM, Kearns AM, Henderson K, Cookson BD, Pearson A, Johnson AP: Decline of EMRSA-16 amongst methicillin-resistant Staphylococcus aureus causing bacteraemias in the UK between 2001 and 2007. J Antimicrob Chemother 2010, 65(3):446-448.
• [30]Novick RP: Mobile genetic elements and bacterial toxinoses: the superantigen-encoding pathogenicity islands of Staphylococcus aureus. Plasmid 2003, 49(2):93-105.
• [31]Linde H, Wagenlehner F, Strommenger B, Drubel I, Tanzer J, Reischl U, Raab U, Holler C, Naber KG, Witte W, et al.: Healthcare-associated outbreaks and community-acquired infections due to MRSA carrying the Panton-Valentine leucocidin gene in southeastern Germany. Eur J Clin Microbiol Infect Dis 2005, 24(6):419-422.
• [32]Otter JA, Havill NL, Boyce JM, French GL: Comparison of community-associated methicillin-resistant Staphylococcus aureus from teaching hospitals in London and the USA, 2004–2006: where is USA300 in the UK? Eur J Clin Microbiol Infect Dis 2009, 28(7):835-839.
• [33]Rossney AS, Shore AC, Morgan PM, Fitzgibbon MM, O'Connell B, Coleman DC: The emergence and importation of diverse genotypes of methicillin-resistant Staphylococcus aureus (MRSA) harboring the Panton-Valentine leukocidin gene (pvl) reveal that pvl is a poor marker for community-acquired MRSA strains in Ireland. J Clin Microbiol 2007, 45(8):2554-2563.
• [34]Boakes E, Kearns AM, Ganner M, Perry C, Warner M, Hill RL, Ellington MJ: Molecular diversity within clonal complex 22 methicillin-resistant Staphylococcus aureus encoding Panton–Valentine leukocidin in England and Wales. Clin Microbiol Infect 2011, 17(2):140-145.
• [35]Ellington MJ, Ganner M, Warner M, Cookson BD, Kearns AM: Polyclonal multiply antibiotic-resistant methicillin-resistant Staphylococcus aureus with Panton-Valentine leucocidin in England. J Antimicrob Chemother 2010, 65(1):46-50.
• [36]Bartels MD, Kristoffersen K, Boye K, Westh H: Rise and subsequent decline of community-associated methicillin resistant Staphylococcus aureus ST30-IVc in Copenhagen, Denmark through an effective search and destroy policy. Clin Microbiol Infect 2010, 16(1):78-83.
• [37]Udo EE, Sarkhoo E: Genetic analysis of high-level mupirocin resistance in the ST80 clone of community-associated meticillin-resistant Staphylococcus aureus. J Med Microbiol 2010, 59(Pt 2):193-199.
• [38]Dsouza N, Rodrigues C, Mehta A: Molecular characterization of Methicillin resistant Staphylococcus aureus (MRSA) with emergence of epidemic clones ST 22 and ST 772, in Mumbai, India. J Clin Microbiol 2010, 48(5):1806-1811.
• [39]Monecke S, Ehricht R, Slickers P, Wernery R, Johnson B, Jose S, Wernery U: Microarray-based genotyping of Staphylococcus aureus isolates from camels. Vet Microbiol 2011, 150(3–4):309-314.
• [40]Moussa I, Shibl AM: Molecular characterization of methicillin-resistant Staphylococcus aureus recovered from outpatient clinics in Riyadh, Saudi Arabia. Saudi Med J 2009, 30(5):611-617.
• [41]Enright MC, Day NPJ, Davies CE, Peacock SJ, Spratt BG: Multilocus Sequence Typing for Characterization of Methicillin-Resistant and Methicillin-Susceptible Clones of Staphylococcus aureus. J Clin Microbiol 2000, 38(3):1008-1015.